drugset / Trial / NCT00204594
Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Phase I/II clinical trial to analyze safety and efficiency of intralesional application of the bispecific single chain antibody rM28 and autologous PBMCs in patients with metastatic melanoma stage III/IV and unresectable metastasis.
Timeline
- Start
- 2005-10
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous PBMCs | Cell therapy | — | Other |
| Subject | rM28 | Unknown | — | Other |